Halozyme Therapeutics Price Chart
Halozyme Therapeutics Volume Chart
Halozyme Therapeutics Market Segments
After Hours
-2.45(-3.08%)
| Open | $79.45 |
|---|---|
| Close | $77.00 |
| Low | $76.84 |
| Low Change | -2.61 (-3.29%) |
| High | $79.45 |
| High Change | +0.00 (+0.00%) |
| Range | $2.61 |
| Volume | 365.009K |
| Dollar Volume | $28.11M |
Regular Trading Hours
+1.64(+2.11%)
| Open | $77.85 |
|---|---|
| Close | $79.49 |
| Low | $77.54 |
| Low Change | -0.31 (-0.40%) |
| High | $79.51 |
| High Change | +1.66 (+2.13%) |
| Range | $1.97 |
| Volume | 1.183M |
| Dollar Volume | $94.05M |
Premarket
+0.00(+0.00%)
| Open | $76.70 |
|---|---|
| Close | $76.70 |
| Low | $76.70 |
| Low Change | 0.00 (0.00%) |
| High | $76.70 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 289 |
| Dollar Volume | $22.17K |
Overnight
*No Trades in Segment
After Hours Yesterday
+0.55(+0.71%)
| Open | $77.01 |
|---|---|
| Close | $77.56 |
| Low | $77.01 |
| Low Change | 0.00 (0.00%) |
| High | $77.56 |
| High Change | +0.55 (+0.71%) |
| Range | $0.55 |
| Volume | 180.393K |
| Dollar Volume | $13.99M |
Regular Trading Hours Yesterday
-1.46(-1.86%)
| Open | $78.47 |
|---|---|
| Close | $77.01 |
| Low | $75.71 |
| Low Change | -2.76 (-3.52%) |
| High | $78.50 |
| High Change | +0.03 (+0.04%) |
| Range | $2.79 |
| Volume | 1.413M |
| Dollar Volume | $108.79M |
Premarket Yesterday
-0.40(-0.51%)
| Open | $78.60 |
|---|---|
| Close | $78.20 |
| Low | $78.16 |
| Low Change | -0.44 (-0.56%) |
| High | $78.60 |
| High Change | +0.00 (+0.00%) |
| Range | $0.44 |
| Volume | 9.025K |
| Dollar Volume | $705.76K |
Halozyme Therapeutics News
Halozyme Therapeutics Top Trades
Halozyme Therapeutics's top trade so far today returned +3.66%, while the top short trade returned -3.36%.
Halozyme Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $76.01 |
|---|---|
| 10 Day Moving Average (SMA10) | $72.69 |
| 20 Day Moving Average (SMA20) | $71.69 |
| 50 Day Moving Average (SMA50) | $68.80 |
| 100 Day Moving Average (SMA100) | $68.63 |
| 200 Day Moving Average (SMA200) | $69.16 |
Halozyme Therapeutics Statistics
| Average Volume (30 Days) | 1.85M |
|---|---|
| P/E Ratio (Current) | 26.62 |
| EPS (Current) | $2.94 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $667.65M |
| Cash Ratio | 0.85 |
| Current Ratio | 2.76 |
| Quick Ratio | 2.33 |
| Debt to Equity | 9.76 |
| Enterprise Value | $11.12B |
| EV to EBITDA | 11.74 |
| EV to Sales | 7.37 |
| Price to Book | 42.27 |
| Price to Cash Flow | 13.70 |
| Price to Free Cash Flow | 13.91 |
| Price to Sales | 6.15 |
| Return on Assets | 0.13% |
| Return on Equity | 1.59% |
Halozyme Therapeutics Stock Splits
There have been no stock splits for Halozyme Therapeutics (HALO).
Halozyme Therapeutics Dividends
There have been no dividends for Halozyme Therapeutics (HALO).